NCT05654974

Brief Summary

Purpose: to assess in Kazakh adult males erect penis sizes, and study an influence of their natural physiological events and behavioral habits during their growing ages on their penile sizes nowadays. Study Design: An observational cross-sectional survey pilot study using a correlational design with the intention-to-treat principle.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
282

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

November 28, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 16, 2022

Completed
Last Updated

October 22, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

November 28, 2022

Last Update Submit

October 19, 2024

Conditions

Keywords

penis sizefrequency of erectionmasturbationcoitussexual abstinencebody growth

Outcome Measures

Primary Outcomes (1)

  • erect penis length and girth

    centimeter

    baseline

Interventions

paper-based survey administration; erect penis length and girth measurements

Eligibility Criteria

Age23 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

A total of 282 adult Kazakh males from the Republic of Kazakhstan and who have been visited at the urology units of three university centers in the biggest cities of the Republic of Kazakhstan (Astana, Almaty, and Karaganda) were prospectively included in the study, which took place between January 2020 and January 2021.

You may qualify if:

  • male gender aged from 23 to 35 years
  • fill out the questionnaire
  • BMI ≤ 29.9 kilogram per meter square
  • a male who has at least one healthy native child
  • no non-communicable chronic diseases.

You may not qualify if:

  • female gender
  • BMI ≥ 30.0 kilogram per meter square
  • infertility
  • erectile dysfunction, previous pelvic surgery, suspected hypogonadism, penile disease, or deformity
  • specific treatment with androgens
  • alcohol or drug abuse
  • history of alcohol consumption ≥ 30 g/day within the past 5 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kuat Pernekulovich Oshakbayev

Astana, 010000, Kazakhstan

Location

MeSH Terms

Conditions

MasturbationCoitusSexual Abstinence

Interventions

Weights and MeasuresSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Sexual BehaviorBehavior

Intervention Hierarchy (Ancestors)

Investigative TechniquesData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Bibazhar Dukenbayeva, Dr.

    ANADETO medical center

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
a principal investigator

Study Record Dates

First Submitted

November 28, 2022

First Posted

December 16, 2022

Study Start

December 1, 2019

Primary Completion

November 30, 2020

Study Completion

January 31, 2021

Last Updated

October 22, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

we will make our data available to any investigator/reviewer on their own request, so that the personal privacy of our patients cannot be compromised

Locations